Study of BHV-1400 in IgA Nephropathy
Public ClinicalTrials.gov record NCT07054684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Biomarker Study of BHV-1400 in IgA Nephropathy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if BHV-1400 is a safe and tolerable treatment in participants with IgA Nephropathy (IgAN).
Study identification
- NCT ID
- NCT07054684
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 20 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 29, 2025
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
- Last update posted
- Jun 22, 2026
2025 – 2027
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site-001 | Farmington | Connecticut | 06030 | Recruiting |
| Site-003 | Miami Lakes | Florida | 33016 | Recruiting |
| Site-011 | Miami Lakes | Florida | 33172 | Recruiting |
| Site-013 | Orlando | Florida | 32806 | Recruiting |
| Site-005 | Pembroke Pines | Florida | 33029 | Recruiting |
| Site-008 | Lawrenceville | Georgia | 30046 | Recruiting |
| Site-009 | Hinsdale | Illinois | 60521 | Recruiting |
| Site-012 | Indianapolis | Indiana | 46268 | Recruiting |
| Site-015 | Shelby | Michigan | 48316 | Recruiting |
| Site-006 | Chesterfield | Missouri | 63017 | Recruiting |
| Site-002 | Dakota Dunes | South Dakota | 57049 | Recruiting |
| Site-014 | Houston | Texas | 77027 | Recruiting |
| Site-004 | Houston | Texas | 77099 | Recruiting |
| Site-016 | Salt Lake City | Utah | 84115 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07054684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2026 · Synced Sep 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07054684 live on ClinicalTrials.gov.